Avatrombopag, also known as AKR-501, YM477, AS 1670542 or E5501, is a novel orally-active thrombopoietin (TPO) receptor agonist. AKR-501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR-501 may be useful in the treatment of patients with thrombocytopenia.
For research use only. We do not sell to patients.
Iupac Chemical Name
AKR501; AKR 501; AKR-501; YM477; YM-477; YM 477; E5501; AS 1670542; AS1670542; AS-1670542; Avatrombopag